Editor’s Note: Find the latest COVID-19 news and guidance from Medscape Coronavirus Resource Center.
The American Diabetes Association (ADA), along with 18 other organizations, sent a letter to the Centers for Disease Control and Prevention (CDC). Type 1 diabetes The severity of COVID-19, and therefore the risk of vaccination, Type 2 diabetes..
January 12, CDC recommended The state immunizes all Americans over the age of 65 and Americans with underlying health who are more vulnerable to COVID-19.
Current, Type 2 diabetes is listed Of the 12 conditions that put adults at “high risk of serious illness due to the virus that causes COVID-19,” the latter are “hospitalization, intensive care unit admission, intubation, or Mechanical ventilation, Or death. “
On the other hand, autoimmune type 1 diabetes is among the 11 states that the CDC states as “potentially at high risk” for COVID-19, as of the last update on December 23, 2020. The data available was limited.
“States use the CDC risk classification when designing vaccine distribution plans, which could lead to approximately 1.6 million people with type 1 diabetes who are vaccinated later than other states with the same risk. That raises obvious concerns. ” ADA letterWas sent to the CDC on January 13th.
Representatives from the Endocrine Socrine, the American Clinical Endocrine Society, the Pediatric Endocrine Society, the Diabetes Care and Education Specialists Association, and the JDRF have signed this letter.
New data show patients at equally high risk for type 1 diabetes
“Early data weren’t very clear about the high risk of type 1 diabetes,” admitting that the ADA has revealed new evidence: Previously reported Along Medscape Medical News, “Convincingly shows that the severity of COVID-19 is more than three times higher in individuals with type 1 diabetes.”
The letter will also quote Another study People with type 1 diabetes are “3.3 times more likely to be seriously ill, 3.9 times more likely to be hospitalized for COVID-19, and 3 times more likely to die than people without type 1 diabetes.” is showing.
They say these risks are comparable to the increased risk established in patients with type 2 diabetes, as shown in a third study in Scotland. Release last month.
Asked for comment, CDC representative Kirsten Nordlund said Medscape Medical News“This list is a living document that is regularly updated by the CDC and can change rapidly as science evolves.”
“Decisions on the transition to the next stage need to depend on supply, demand, equitable vaccine distribution, and local, state, or territorial conditions,” Nordland said.
“Step-by-step vaccine recommendations are fluid and do not limit jurisdiction. It is not necessary to vaccinate all individuals at one stage before starting the next stage. Stages can overlap. There is sex, “she said.More information available here..
Tennessee equalizes vaccination priorities for type 1 and type 2 diabetes
Meanwhile, at least one state, Tennessee, has updated its guidance to include both types of diabetes as a priority for COVID-19 vaccination.
Justin M. Gregory, MD, Ph.D., Pediatric Endocrinologist, Vanderbilt University Medscape Medical News: “I was thrilled when our state changed its guidance on December 30th to include both type 1 and type 2 diabetes in the” high risk category. ” However, other states have not changed that guidance. “
It’s unclear how this works on the ground, said Gregory, who led one of the three studies. Increase in COVID-19 Risk for people with type 1 diabetes.
“To tell the truth, I’m not sure how individual tissues are vaccinated. [will handle] People who come to the facility saying “diabetes”. Individual states have set up vaccine dispensing guidance, and the health departments and health systems of individual counties reflect that guidance. “
Therefore, if he says that a person with type 1 diabetes has “diabetes”, a website, and a health department, the individual nurse will say, “I don’t ask you, you lie to me. You may take a “no-use” approach, but the recorded phone message will have to wait for people with type 1 diabetes to return further, if it is instructed by state guidance. I will tell you that it will not be. “